A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma

Riki Toita1, Masaharu Murata, Kana Abe

  • 1Department of Advanced Medical Initiatives, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka 812-8582, Japan.

Chemical Communications (Cambridge, England)
|July 18, 2013
PubMed